<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00115479</url>
  </required_header>
  <id_info>
    <org_study_id>S18630</org_study_id>
    <secondary_id>FWO grant number G.0278.03</secondary_id>
    <secondary_id>KULeuven OT/03/56</secondary_id>
    <nct_id>NCT00115479</nct_id>
  </id_info>
  <brief_title>KULeuven Intensive Insulin Therapy Study in Medical Intensive Care Patients</brief_title>
  <official_title>KULeuven Intensive Insulin Therapy Study in Medical Intensive Care Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>KU Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fund for Scientific Research, Flanders, Belgium</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Novo Nordisk A/S</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>KU Leuven</source>
  <brief_summary>
    <textblock>
      In a previous study, we showed that tight blood glucose control with insulin during intensive&#xD;
      care reduced morbidity and mortality of surgical intensive care patients. Whether this&#xD;
      intervention also improves prognosis of medical intensive care patients remains unknown. The&#xD;
      current prospective, randomized, controlled study will assess the impact of intensive insulin&#xD;
      therapy on the outcome of patients in a medical intensive care unit. On admission, patients&#xD;
      will be randomly assigned to either strict normalization of blood glucose (80-110 mg/dl) with&#xD;
      intensive insulin therapy or the conventional approach, in which insulin infusion is&#xD;
      initiated only when blood glucose exceeds 215 mg/dl, to maintain blood glucose levels between&#xD;
      180 and 200 mg/dl.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In a previous study, we showed that tight blood glucose control with insulin during intensive&#xD;
      care reduced morbidity and mortality of surgical intensive care patients. Whether this&#xD;
      intervention also improves prognosis of medical intensive care patients remains unknown. The&#xD;
      current prospective, randomized, controlled study will assess the impact of intensive insulin&#xD;
      therapy on the outcome of patients in a medical intensive care unit. On admission, patients&#xD;
      will be randomly assigned to either strict normalization of blood glucose (80-110 mg/dl) with&#xD;
      intensive insulin therapy or the conventional approach, in which insulin infusion is&#xD;
      initiated only when blood glucose exceeds 215 mg/dl, to maintain blood glucose levels between&#xD;
      180 and 200 mg/dl.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2002</start_date>
  <completion_date>June 2005</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>mortality</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>mechanical ventilatory support-dependency</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>stay in Intensive Care Unit (ICU)</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>stay in hospital</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>organ failure</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>morbidity</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>a long-term follow up is planned to take place 6 and 12 months after hospital discharge</measure>
  </secondary_outcome>
  <enrollment>1200</enrollment>
  <condition>Critical Illness</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>intensive insulin therapy to maintain normoglycemia</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults admitted to ICU and anticipated to require intensive care for at least a few&#xD;
             days&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Expected short ICU stay&#xD;
&#xD;
          -  Therapy restricted upon admission&#xD;
&#xD;
          -  Surgical ICU patients&#xD;
&#xD;
          -  Other studies&#xD;
&#xD;
          -  Below 18 years&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Greet H Van den Berghe, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>K.U.Leuven</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Catholic University of Leuven, University Hospital Gasthuisberg</name>
      <address>
        <city>Leuven</city>
        <zip>B-3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001 Nov 8;345(19):1359-67.</citation>
    <PMID>11794168</PMID>
  </reference>
  <results_reference>
    <citation>Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006 Feb 2;354(5):449-61.</citation>
    <PMID>16452557</PMID>
  </results_reference>
  <verification_date>June 2005</verification_date>
  <study_first_submitted>June 22, 2005</study_first_submitted>
  <study_first_submitted_qc>June 22, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 23, 2005</study_first_posted>
  <last_update_submitted>May 3, 2006</last_update_submitted>
  <last_update_submitted_qc>May 3, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 4, 2006</last_update_posted>
  <keyword>critical illness</keyword>
  <keyword>intensive care</keyword>
  <keyword>outcome</keyword>
  <keyword>insulin</keyword>
  <keyword>blood glucose</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Benzocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

